全部分类



Sevelamer Carbonate Tablets

This product is indicated for the control of hyperphosphatemia in CKD adults on dialysis.

Product Category：

Product Description

[Product Name] Kaweilarui^®

[Generic Name] Sevelamer Carbonate Tablets

[Approval No.] GYZZ HJ20230042

[Specification] JX20230021

[Dosage and Administration] The recommended initial dose is 0.8 g or 1.6 g three times daily, taken with food.

[Indications]

1. Control of hyperphosphatemia in adults with chronic kidney disease (CKD) on dialysis;

2. Control of hyperphosphatemia in CKD adults with serum phosphorus ≥1.78 mmol/L but not on dialysis.

[Strength] 800 mg*30 tablets/carton.

[Storage] Store in airtight containers in a dry place, protected from light.

[Shelf Life] 36 months.

[Manufacturer] Dr. Reddy's Laboratories Ltd.

[China General Distributor] Shenzhen Foncoo Pharmaceutical Co., Ltd.

ONLINE MESSAGE

*Note: Please be sure to fill in the information accurately and keep the communication open, we will get in touch with you as soon as possible